- The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury2023 | Second Faculty of Medicine
- An overview of treatment modalities in neuroendocrine neoplasias2013 | First Faculty of Medicine
- Everolimus in the treatment of metastatic renal cell cancer2014 | First Faculty of Medicine
- News in the treatment of metastatic renal cell carcinoma2018 | First Faculty of Medicine
- Renal cell carcinoma2015 | First Faculty of Medicine
- Cílená léčba renálního karcinomu2016 | First Faculty of Medicine
- Cabozantinib in the treatment of RCC2018 | First Faculty of Medicine
- Metformin – a new star in cancer treatment?2012 | First Faculty of Medicine
- Renální karcinom2017 | First Faculty of Medicine
- Renal cell carcinoma - current practice in 20192020 | First Faculty of Medicine
- Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative2017 | First Faculty of Medicine
- Management of the metastatic renal cancer2023 | Faculty of Medicine in Hradec Králové
- Src-dependent activation of the mTOR signaling in melanoma cells2012 | First Faculty of Medicine
- Importance of ERK1/2 in Regulation of Protein Translation during Oocyte Meiosis2018 | Faculty of Science
- Severe Hyperinsulinemic Hypoglycemia in a Neonate: Response to Sirolimus Therapy2015 | Second Faculty of Medicine
- Hemodiafiltration and plasma levels of axitinib in a patient with metastatic renal clear cell carcinoma2018 | Faculty of Medicine in Hradec Králové
- mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis2022 | First Faculty of Medicine
- A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development2023 | Faculty of Science
- Nontuberculous mycobacterial infection after therapy with temsirolimus for metastatic renal cell carcinoma2013 | First Faculty of Medicine
- Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells2013 | First Faculty of Medicine, Third Faculty of Medicine
- Review of renal tumors associated with Birt-Hogg-Dube syndrome with focus on clinical and pathobiological aspects2014 | Faculty of Medicine in Pilsen
- Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of L-asparaginase in childhood ALL cells2016 | Second Faculty of Medicine, Faculty of Science, Central Library of Charles University
- Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma2023 | First Faculty of Medicine
- Involvement of mTOR Pathways in Recovery from Spinal Cord Injury by Modulation of Autophagy and Immune Response2021 | Second Faculty of Medicine
- A Cyclic Pentamethinium Salt Induces Cancer Cell Cytotoxicity through Mitochondrial Disintegration and Metabolic Collapse2019 | First Faculty of Medicine
- Molecular Targets for Cancer Therapy in the PI3K/AKT/mTOR Pathway2014 | Faculty of Medicine in Pilsen
- Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex2016 | Second Faculty of Medicine
- MRE11 stability is regulated by CK2-dependent interaction with R2TP complex2017 | Faculty of Science
- Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes2021 | Third Faculty of Medicine
- Diagnostic methods and treatment options for focal cortical dysplasia2015 | Second Faculty of Medicine